Progenics Pharma 4Q Loss 36c/Share
DOW JONES NEWSWIRES
Progenics Pharmaceuticals Inc. - Tarrytown, N.Y.
4th Quar Dec. 31:
2001 2000
Revenue $2,667,453 $3,522,976
Net income (4,478,866) (2,463,376)
Shr earns
Net income (.36) (.20)
Year:
Revenue 12,232,040 13,949,429
Net income (1,898,150) (5,917,156)
Shr earns
Net income (.15) (.49)
Figures in parentheses are losses.
Progenics Pharmaceuticals Inc. (PGNX), a biopharmaceutical company, received a $9.8 million payment in 2001 in connection with the termination of its collaboration with Bristol-Myers Squibb Co. (BMY).
Company Web site: progenics.com |
